We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 377

High Hopes and Torched Dreams
  • Burns & Levinson LLP
  • USA
  • June 27 2018

This week’s cannabis news was filled with high hopes for some and torched dreams for others. On the one hand, the Food and Drug Administration made


Recent State Court Decisions and FDA Inaction Leave Brand Name Manufacturers Uncertain About Liability for Updating Safety Labeling: The Impact of the “Sameness” Standard
  • Epstein Becker Green
  • USA
  • March 30 2018

Two cases decided over the last three months have added California and Massachusetts to the list of minority states that hold brand name


Insys Therapeutics Runs Afoul of Attorneys General in Two States
  • FisherBroyles LLP
  • USA
  • October 10 2017

Arizona-based pharmaceutical company Insys Therapeutics Inc. (Insys) has found itself under investigation in both Massachusetts and New Jersey over


Pharmacist at Center of 2012 Fungal Meningitis Outbreak Sentenced to 9 Years in Prison
  • FisherBroyles LLP
  • USA
  • June 30 2017

Earlier this year a federal court jury in Boston found the owner of a now-defunct compounding pharmacy guilty of racketeering and fraud for his role


First Circuit Rejects Whistleblower’s Fraud on the FDA FCA Theory
  • Ropes & Gray LLP
  • USA
  • January 4 2017

On December 23, 2016, the First Circuit held that a relator under the federal False Claims Act (“FCA”) failed to plausibly plead that defendant


Massachusetts Court Weighs in on Product Hopping Allegations and Reverse Payment Standing
  • McDermott Will & Emery
  • USA
  • November 11 2016

Addressing a motion to dismiss a bevy of antitrust allegations, the US District Court for the District of Massachusetts held that a class of


Massachusetts Rebuffs Latest Plaintiff Attack on Reproductive Choice
  • Reed Smith LLP
  • USA
  • October 5 2016

We’ve often thought that tort reform should be a major goal of those interested in preserving women’s reproductive choice. Every prescription


Another Rejection of Innovator Liability
  • Dechert LLP
  • USA
  • June 6 2016

It’s been a bit of a slow news week in the drug and device litigation world. We are coming off a short work week and like the rest of us, judges may


Massachusetts Passes Drug Stewardship Program Law
  • Porzio Bromberg & Newman PC
  • USA
  • March 30 2016

The Governor of Massachusetts recently approved legislation that will require pharmaceutical product manufacturers that sell or distribute a covered


Freehand line-drawing in affirmance of huge verdict in Children’s MotrinTEN case
  • Reed Smith LLP
  • USA
  • April 30 2015

A couple of days ago, we watched the lovely "St. Vincent." The film stars a spot-on Bill Murray as Vincent, an unemployed curmudgeon living alone in